Adult All clinical trials

Explore recruiting adult all clinical trials.

Recruiting adult all studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adult All trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I/II, open label, multicenter study of rapcabtagene autoleucel in adult patients with CLL/SLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL

France, Spain, Germany, Austria, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A phase I safety, dose finding and feasibility trial of MB-CART19.1 in patients with relapsed or refractory CD19 positive B cell malignancies

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Long-Term Follow-up of Patients Treated with Miltenyi Cell and Gene Therapies

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Adult All trials by city

Adult All in Toronto Adult All in Vancouver Adult All in Montreal Adult All in Calgary Adult All in Edmonton Adult All in Ottawa Adult All in Winnipeg Adult All in Quebec City Adult All in Hamilton Adult All in Kitchener Adult All in London Adult All in Halifax Adult All in New York Adult All in Los Angeles Adult All in Chicago Adult All in Houston

Adult All clinical trials

Recruiting adult all studies right now

CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

CD7 CAR-T Cells in T-cell Lymphoma/Leukemia

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Also recruiting in Europe

Phase I/II, open label, multicenter study of rapcabtagene autoleucel in adult patients with CLL/SLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL

A phase I safety, dose finding and feasibility trial of MB-CART19.1 in patients with relapsed or refractory CD19 positive B cell malignancies

Long-Term Follow-up of Patients Treated with Miltenyi Cell and Gene Therapies

Adult All trials by city

Other conditions